GlobeNewswire Inc.··Dndi And SanofiDNDi-Sanofi sleeping sickness drug wins EMA backing as simplified single-dose option
EMA approves DNDi-Sanofi's Acoziborole Winthrop, a simplified single-dose sleeping sickness treatment with 96% efficacy. Sanofi will donate it to WHO for endemic countries.
SNYsleeping sicknessCHMP approval